JPRN-UMIN000008602已完成未知
Identifing the markers for chemotherapy - induced liver damage - Identifing the markers for chemotherapy - induced liver damage
Yokohama City University, Department of Gastroenterological Surgery0 个研究点目标入组 100 人开始时间: 2012年8月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Chemotherapy Related Biomarker in Triple negative breast cancerCTRI/2018/05/014158Tata Memorial Centre
招募中
不适用
Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.inflammatory bowel disease10017969NL-OMON50587Interne geneeskunde/Divisie MD5,000
进行中（未招募）
1 期
A new magnetic resonance scanning technology for monitoring therapy effects in patients with Pancreatic cancer.MedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864EUCTR2016-004491-22-DKDept. Clinical Medicine, Aarhus Universit15
进行中（未招募）
不适用
Induction chemotherapy followed by chemoradiation with cetuximab and cisplatin for inoperable squamous cell carcinoma of the head and neck.Inoperable squamous cell carcinoma of the head and neck.EUCTR2006-003381-33-SIInstitute of Oncology Ljubljana
进行中（未招募）
1 期
Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01MedDRA version: 21.1Level: LLTClassification code: 10008229Term: Cervical cancer Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10008236Term: Cervical cancer stage IV Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10008235Term: Cervical cancer stage III Class: 10029104Cervical CancerCTIS2024-513576-18-00Centre Hospitalier Universitaire De Toulouse310